Overview

• The Attorney General’s Office filed the petition at 23:26 on the final day of the Superior Court of Justice deadline, asking for 180 more days to complete analysis and consultations.
• STJ Minister Regina Helena will decide on the request after the court ordered regulation last November and previously extended timelines, with one prior plea for extra time denied.
• The pending norm would cover seed importation, planting, cultivation and commercialization for medicinal and pharmaceutical purposes.
• Patient groups and industry figures, including Farmacann, argue the new delay harms access to treatment and deepens legal uncertainty, encouraging more litigation.
• Import dependence remains high as Anvisa has accepted requests since 2015, with daily averages rising from about 2 to 490, while 2019-approved domestic products are few and expensive.